Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease

MM McDermott, K Liu, L Ferrucci, L Tian… - Journal of the American …, 2011 - jacc.org
MM McDermott, K Liu, L Ferrucci, L Tian, JM Guralnik, Y Liao, MH Criqui
Journal of the American College of Cardiology, 2011jacc.org
Objectives: We hypothesized that a greater 2-year decline in office-based functional
performance measures would be associated with greater mobility loss and mortality in
people with peripheral arterial disease (PAD). Background: Associations of decline in
functional performance with clinically important outcomes in patients with PAD are unknown.
Methods: A total of 440 men and women with PAD completed the 6-min walk test and
measures of walking velocity at baseline and annually for 2 years. Participants were …
Objectives
We hypothesized that a greater 2-year decline in office-based functional performance measures would be associated with greater mobility loss and mortality in people with peripheral arterial disease (PAD).
Background
Associations of decline in functional performance with clinically important outcomes in patients with PAD are unknown.
Methods
A total of 440 men and women with PAD completed the 6-min walk test and measures of walking velocity at baseline and annually for 2 years. Participants were categorized into tertiles according to their functional decline between baseline and 2-year follow-up and were followed annually after the functional change assessment. Cox proportional hazard models were used to assess relations between the 2-year change in functional performance with later mortality and mobility loss, with adjustments for age, sex, race, ankle brachial index, comorbidities, and other confounders.
Results
A total of 102 participants (23.2%) died during a median follow-up of 44.5 months after functional change was assessed. Of 319 participants without baseline mobility disability, 60 (18.8%) developed mobility loss after functional change was assessed. Participants in the tertile with the greatest 6-min walk decline had the highest subsequent mobility loss (hazard ratio [HR]: 3.50; 95% confidence interval [CI]: 1.56 to 7.85; p = 0.002), all-cause mortality (HR: 2.16; 95% CI: 1.28 to 3.64; p = 0.004), and cardiovascular disease mortality (HR: 2.45; 95% CI: 1.08 to 5.54; p = 0.031), compared with those with the smallest 6-min walk decline. Greater declines in fastest-paced 4-m walking velocity were associated with higher mobility loss (p trend = 0.018), all-cause mortality (p trend = 0.01), and cardiovascular mortality (p trend = 0.004).
Conclusions
Participants with PAD with declining functional performance are at increased risk for later mobility loss and mortality.
jacc.org